What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Internal medicine, Oncology, Pathology, Cancer research and Fluorescence in situ hybridization.
His Internal medicine research is multidisciplinary, relying on both Surgery and Oligodendroglioma.
The concepts of his Oncology study are interwoven with issues in Chemotherapy, Breast cancer, Trastuzumab, Guideline and Radiation therapy.
His Pathology research incorporates themes from Chromosome and Prostate.
He combines subjects such as Carcinogenesis, Tumor suppressor gene, Gene and Mutation with his study of Cancer research.
He usually deals with Fluorescence in situ hybridization and limits it to topics linked to Cytogenetics and Chromosome 7.
His most cited work include:
- Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer (4382 citations)
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update (1998 citations)
- Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer (1179 citations)
What are the main themes of his work throughout his whole career to date?
Robert B. Jenkins spends much of his time researching Internal medicine, Oncology, Pathology, Cancer research and Glioma.
The study of Internal medicine is intertwined with the study of Surgery in a number of ways.
His work deals with themes such as Radiation therapy, Chemotherapy, Temozolomide and Prostate cancer, which intersect with Oncology.
His Pathology research includes elements of Fluorescence in situ hybridization, Chromosome, Cytogenetics and Oligodendroglioma.
Robert B. Jenkins interconnects Carcinogenesis, Tumor suppressor gene, Mutation, Germline and PTEN in the investigation of issues within Cancer research.
His Glioma research focuses on Genome-wide association study and how it connects with Genetic association.
He most often published in these fields:
- Internal medicine (34.09%)
- Oncology (30.37%)
- Pathology (28.11%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (34.09%)
- Oncology (30.37%)
- Glioma (20.52%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Glioma, Cancer research and Gene.
His Oncology research is multidisciplinary, incorporating perspectives in Odds ratio, Clinical Oncology, Temozolomide, Breast cancer and Oligodendroglioma.
His Glioma study incorporates themes from Single-nucleotide polymorphism, Genome-wide association study, Genotype and Case-control study.
As a part of the same scientific study, Robert B. Jenkins usually deals with the Cancer research, concentrating on Germline and frequently concerns with Diffuse Glioma.
His work carried out in the field of Gene brings together such families of science as Molecular biology and Computational biology.
His Prostate cancer study combines topics from a wide range of disciplines, such as Prostate and Metastasis.
Between 2017 and 2021, his most popular works were:
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (270 citations)
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (241 citations)
- cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (228 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Glioma, Internal medicine, Oncology, Gene and Cancer research.
His Glioma study combines topics in areas such as Obesity, Epidemiology, Case-control study, Pathology and Brain tumor.
The various areas that Robert B. Jenkins examines in his Pathology study include Chromosome 9 and Distribution.
His biological study spans a wide range of topics, including Guideline and Single-nucleotide polymorphism.
His Oncology research incorporates elements of Breast cancer, Human Epidermal Growth Factor Receptor 2, Angiogenesis, Retrospective cohort study and O-6-methylguanine-DNA methyltransferase.
His Cancer research study integrates concerns from other disciplines, such as Insertional mutagenesis, Transposon mutagenesis and Carcinogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
